CCN1 and adrenal cortex carcinoma: As a result, CYR61 was downregulated in most of the cancer types, such as BRCA, adrenocortical carcinoma (ACC), bladder urothelial carcinoma (BLCA), kidney chromophobe (KICH) and liver hepatocellular carcinoma (LIHC), amongst others (Figure 1A).